Distant recurrences in triple negative breast cancer (TNBC) according to androgen receptor (AR) status.

被引:0
|
作者
Tung, Nadine M.
Garber, Judy Ellen
Hacker, Michele R.
Torous, Vanda
Nalven, Tessa
Alexander, Brian Michael
Lee, Larissa Janeen
Collins, Laura C.
Schnitt, Stuart J.
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Sch Publ Hlth, Boston, MA USA
[4] Brigham & Womens Canc Ctr, Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Rad Onc Prog, Boston, MA USA
[6] Harvard Med Sch, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.1085
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1085
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Imaging features of triple-negative breast cancers according to androgen receptor status
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Wei, Wei
    Thompson, Alastair M.
    Santiago, Lumarie
    Lane, Deanna L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Symmans, W. Fraser
    Gilcrease, Michael Z.
    Huo, Lei
    Lim, Bora
    Ueno, Naoto T.
    Moulder, Stacy L.
    Yang, Wei Tse
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 114 : 167 - 174
  • [22] Androgen receptor (AR) expression in triple negative breast cancer (TNBC): results from a phase II neoadjuvant trial with carboplatin and eribulin mesylate in TNBC patients
    Siziopikou, K.
    Parini, V.
    Kaklamani, V.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 14 - 14
  • [23] Androgen receptor in triple negative breast cancer
    McNamara, K. M.
    Yoda, T.
    Takagi, K.
    Miki, Y.
    Suzuki, T.
    Sasano, H.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2013, 133 : 66 - 76
  • [24] Clinico-pathological relationship between androgen receptor (AR) and tumor infiltrating lymphocytes (TILs) in triple negative breast cancer (TNBC)
    Elghazawy, H.
    Alorabi, M. O.
    Helal, T.
    Aref, A.
    Kelany, M.
    Abdallah, L. A. Eid
    Sayed, F.
    Ali, D.
    Zaki, D.
    Ahmed, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 22 - +
  • [25] Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC)
    Ricciardi, Giuseppina R. R.
    Adamo, Barbara
    Ferraro, Giuseppa
    Franchina, Tindara
    Zanghi, Mariangela
    Buda, Carmelo
    Trimarchi, Giuseppe
    Cardia, Roberta
    Tuccari, Giovanni
    Adamo, Vincenzo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Triple-negative invasive breast cancer (TNBC): Mammographic, US, and MR imaging features according to androgen receptor (R) expression
    Moon, Woo Kyung
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [27] Androgen Receptor (AR) as a Mediator and Biomarker of Radioresistance in Triple-Negative Breast Cancer
    Lee, Alice
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (02): : 440 - 441
  • [28] Androgen Receptor (AR) As a Mediator and Biomarker of Radioresistance in Triple-Negative Breast Cancer
    Speers, C.
    Zhao, S. G.
    Santola, A.
    Liu, M.
    Wilder-Romans, K.
    Alluri, P. G.
    Lawrence, T. S.
    Feng, F.
    Pierce, L. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S17 - S17
  • [29] P16 Expression is correlated with Androgen Receptor (AR) expression in Triple-Negative Breast Cancers (TNBC)
    Yoon, Esther
    Wilson, Parker
    Irshaid, Lina
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    MODERN PATHOLOGY, 2019, 32
  • [30] Association between androgen receptor status and prognosis in triple negative breast cancer
    Sunar, Veli
    Dogan, Hayriye T.
    Sarici, Furkan
    Ates, Ozturk
    Akin, Serkan
    Baspinar, Batuhan
    Aksoy, Sercan
    Altundag, Kadri
    JOURNAL OF BUON, 2018, 23 (05): : 1325 - 1330